BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haal S, Guman MSS, Boerlage TCC, Acherman YIZ, de Brauw LM, Bruin S, de Castro SMM, van Hooft JE, van de Laar AWJM, Moes DE, Schouten M, Schouten R, van Soest EJ, van Veen RN, de Vries CEE, Fockens P, Dijkgraaf MGW, Gerdes VEA, Voermans RP. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial. Lancet Gastroenterol Hepatol 2021;6:993-1001. [PMID: 34715031 DOI: 10.1016/S2468-1253(21)00301-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Blank S, Otto M, Belle S. [Cholecystolithiasis and intestinal bypass procedures]. Chirurgie (Heidelb) 2023. [PMID: 36884048 DOI: 10.1007/s00104-023-01834-9] [Reference Citation Analysis]
2 Song P, Zhang X, Feng W, Xu W, Wu C, Xie S, Yu S, Fu R. Biological synthesis of ursodeoxycholic acid. Front Microbiol 2023;14:1140662. [PMID: 36910199 DOI: 10.3389/fmicb.2023.1140662] [Reference Citation Analysis]
3 Belgau I, Johnsen G, Græslie H, Mårvik R, Nymo S, Bjerkan K, Hyldmo Å, Klöckner C, Kulseng B, Hoff D, Sandvik J. Frequency of cholelithiasis in need of surgical or endoscopic treatment a decade or more after Roux-en-Y gastric bypass. Surg Endosc 2023;37:1349-56. [PMID: 36203112 DOI: 10.1007/s00464-022-09676-y] [Reference Citation Analysis]
4 Son SY, Song JH, Shin HJ, Hur H, Han SU. Prevention of Gallstones After Bariatric Surgery using Ursodeoxycholic Acid: A Narrative Review of Literatures. J Metab Bariatr Surg 2022;11:30-8. [PMID: 36926672 DOI: 10.17476/jmbs.2022.11.2.30] [Reference Citation Analysis]
5 Choi YS, Cha B, Kim SH, Yi JW, Kim KD, Choi MS, Heo YS. Clinical Characteristics of Symptomatic Cholecystitis in Post-Gastrectomy Patients: 11 Years of Experience in a Single Center. Medicina (Kaunas) 2022;58. [PMID: 36295611 DOI: 10.3390/medicina58101451] [Reference Citation Analysis]
6 Haal S, Guman MSS, de Brauw LM, Schouten R, van Veen RN, Fockens P, Gerdes VEA, Voermans RP, Dijkgraaf MGW. Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery. British Journal of Surgery 2022;109:1116-1123. [DOI: 10.1093/bjs/znac273] [Reference Citation Analysis]
7 Jiao JY, Zhu XJ, Zhou C, Wang P. Research progress on the immune microenvironment of the gallbladder in patients with cholesterol gallstones. World J Gastrointest Surg 2022; 14(9): 887-895 [DOI: 10.4240/wjgs.v14.i9.887] [Reference Citation Analysis]
8 Guman MSS, Hoozemans JB, Haal S, de Jonge PA, Aydin Ö, Lappa D, Meijnikman AS, Westerink F, Acherman Y, Bäckhed F, de Brauw M, Nielsen J, Nieuwdorp M, Groen AK, Gerdes VEA. Adipose tissue, bile acids, and gut microbiome species associated with gallstones after bariatric surgery. J Lipid Res 2022;:100280. [PMID: 36115596 DOI: 10.1016/j.jlr.2022.100280] [Reference Citation Analysis]
9 Ilchishina TA, Kucheryavyy YA, Sviridova TN. Prevention and treatment of some gastrointestinal complications after bariatric surgery: A review. Consilium Medicum 2022;24:312-316. [DOI: 10.26442/20751753.2022.5.201731] [Reference Citation Analysis]
10 Wang D, Liu J, Zhou L, Zhang Q, Li M, Xiao X. Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites. Front Endocrinol 2022;13:905171. [DOI: 10.3389/fendo.2022.905171] [Reference Citation Analysis]
11 Zhang LY, Irani S, Khashab MA. Biliary Endoscopy in Altered Anatomy. Gastrointest Endosc Clin N Am 2022;32:563-82. [PMID: 35691697 DOI: 10.1016/j.giec.2022.02.001] [Reference Citation Analysis]
12 Ying J, Dai S, Fu R, Hong J, Dai C, Jin Q. Effect of ursodeoxycholic acid on gallstone formation after bariatric surgery: An updated meta-analysis. Obesity (Silver Spring) 2022. [PMID: 35475596 DOI: 10.1002/oby.23427] [Reference Citation Analysis]
13 . Beugt Ursodeoxycholsäure der Gallensteinbildung nach bariatrischer OP vor? Z Gastroenterol 2022;60:154-154. [DOI: 10.1055/a-1710-2633] [Reference Citation Analysis]
14 Haal S, Guman MSS, Bruin S, Schouten R, van Veen RN, Fockens P, Dijkgraaf MGW, Hutten BA, Gerdes VEA, Voermans RP. Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery. Obes Surg 2022. [PMID: 35143012 DOI: 10.1007/s11695-022-05947-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Guman MS, Haal S, de Brauw LM, Hutten BA, Nieuwdorp M, Nuijen B, Schouten R, van Veen RN, Dijkgraaf MG, Voermans RP, Gerdes VE. Factors associated with adherence to ursodeoxycholic acid or placebo in patients after bariatric surgery. Surgery for Obesity and Related Diseases 2022. [DOI: 10.1016/j.soard.2022.02.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Verhoeff K, Mocanu V, Dang J, Switzer NJ, Birch DW, Karmali S. Characterization and Risk Factors for Early Biliary Complications Following Elective Bariatric Surgery: an Mbsaqip Analysis. Obes Surg 2022. [PMID: 35048248 DOI: 10.1007/s11695-022-05914-3] [Reference Citation Analysis]
17 易 付. Research Progress on Mechanism, Prevention and Treatment of Gallstone Formation after Gastrectomy. ACM 2022;12:3214-3220. [DOI: 10.12677/acm.2022.124463] [Reference Citation Analysis]
18 Welbourn R, Pournaras DJ. Bariatric surgery and prophylaxis against symptomatic gallstone disease. Lancet Gastroenterol Hepatol 2021;6:972-3. [PMID: 34715030 DOI: 10.1016/S2468-1253(21)00383-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]